These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

71 related items for PubMed ID: 9156411

  • 41. Low molecular weight heparin versus acenocoumarol in the secondary prophylaxis of deep vein thrombosis.
    Lopaciuk S, Bielska-Falda H, Noszczyk W, Bielawiec M, Witkiewicz W, Filipecki S, Michalak J, Ciesielski L, Mackiewicz Z, Czestochowska E, Zawilska K, Cencora A.
    Thromb Haemost; 1999 Jan; 81(1):26-31. PubMed ID: 9974369
    [Abstract] [Full Text] [Related]

  • 42. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P, Behounek J, Skoták M, Nevsímal L.
    Acta Chir Orthop Traumatol Cech; 2004 Jan; 71(4):237-44. PubMed ID: 15456102
    [Abstract] [Full Text] [Related]

  • 43. Oral anticoagulant therapy in venous thromboembolism.
    Cosmi B, Palareti G.
    Semin Vasc Med; 2003 Aug; 3(3):303-14. PubMed ID: 15199464
    [Abstract] [Full Text] [Related]

  • 44. Dosage, anticoagulant, and antithrombotic effects of heparin and low-molecular-weight heparin in the treatment of deep vein thrombosis.
    Harenberg J, Stehle G, Blauth M, Huck K, Mall K, Heene DL.
    Semin Thromb Hemost; 1997 Aug; 23(1):83-90. PubMed ID: 9156415
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Low molecular weight heparin versus acenocoumarol in the secondary prophylaxis of deep vein thrombosis.
    Lopaciuk S, Bielska-Falda H, Noszczyk W, Bielawiec M, Witkiewicz W, Filipecki S, Michalak J, Ciesielski L, Mackiewicz Z, Czestochowska E, Zawilska K, Cencora A.
    Thromb Haemost; 1999 Jan; 81(1):26-31. PubMed ID: 9974369
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Oral anticoagulant therapy in venous thromboembolism.
    Cosmi B, Palareti G.
    Semin Vasc Med; 2003 Aug; 3(3):303-14. PubMed ID: 15199464
    [Abstract] [Full Text] [Related]

  • 49. Dosage, anticoagulant, and antithrombotic effects of heparin and low-molecular-weight heparin in the treatment of deep vein thrombosis.
    Harenberg J, Stehle G, Blauth M, Huck K, Mall K, Heene DL.
    Semin Thromb Hemost; 1997 Aug; 23(1):83-90. PubMed ID: 9156415
    [Abstract] [Full Text] [Related]

  • 50. Prevention of recurrences after deep venous thrombosis: role of low-molecular-weight heparins.
    Pini M.
    Semin Thromb Hemost; 1997 Aug; 23(1):51-4. PubMed ID: 9156411
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Low-molecular-weight heparin (LMWH) in the treatment of thrombosis.
    Holzheimer RG.
    Eur J Med Res; 2004 Apr 30; 9(4):225-39. PubMed ID: 15210403
    [Abstract] [Full Text] [Related]

  • 53. Low-molecular-weight heparins for the treatment of deep-vein thrombosis.
    Cziraky MJ, Spinler SA.
    Clin Pharm; 1993 Dec 30; 12(12):892-9. PubMed ID: 8137606
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. The role of low molecular weight heparin in total knee arthroplasty.
    Iobst CA, Friedman RJ.
    Am J Knee Surg; 1999 Dec 30; 12(1):55-60. PubMed ID: 10050695
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.